Navigation Links
LSUHSC student awarded top national honor for diabetes research

New Orleans, LA Sharell Bindom, a student in the MD/PhD program at LSU Health Sciences Center New Orleans, will be awarded the Mead Johnson Research Award in Endocrinology and Metabolism by the American Physiological Society at the 2009 Experimental Biology Meeting April 18-22 in New Orleans. This award, which includes a check for $500, is intended to recognize the graduate student, resident, or postdoctoral fellow who presents the best abstract for research in the area of Endocrinology and Metabolism at the Experimental Biology Meeting. She works in the laboratory of Eric Lazartigues, PhD, Assistant Professor of Pharmacology and Experimental Therapeutics at LSU Health Sciences Center New Orleans.

Bindom's abstract is entitled, "ACE2 gene therapy leads to Ang-(1-7)-mediated restoration of glucose metabolism in diabetic mice." She will present it on Tuesday, April 21, 2009 at 9:00 a.m. in Room 242 at the Ernest N. Morial Convention Center. The research team previously demonstrated that glucose tolerance and fasting blood glucose levels in diabetic mice were improved when the pancreas overproduced Angiotensin-converting enzyme (ACE) 2. They hypothesized that the improvement in glucose stability could be achieved by enhancing pancreatic beta cell function. Beta cells are located in islet cell clusters throughout the pancreas. Diabetes mellitus type 1 results from the destruction or dysfunction of islets and their beta cells. Type 2 diabetes results from the body's inability to use insulin properly and a gradual decrease in the pancreas's ability to make it.

Through a series of experiments, the LSUHSC research team found that ACE2 gene therapy improves pancreatic beta cell function and restores glucose stability by increasing the activity of a peptide called Angiotensin (1-7), or Ang (1-7).


Contact: Leslie Capo
Louisiana State University Health Sciences Center

Page: 1

Related biology news :

1. LSUHSC research identifies key contributor to Alzheimers disease process
2. LSUHSC awarded patent for compound inhibiting cancer and other diseases
3. LSUHSC research reports new method to protect brain cells from diseases like Alzheimers
4. LSUHSCs Lazartigues awarded $1.2 million grant
5. LSUHSC awarded $10M+ COBRE grant
6. Tufts students host Earth Day with groundbreaking ceremony for solar house
7. Virginia Tech graduate student receives first Rachel Carson award for scientific excellence
8. K-State using Second Life island to help high school students learn earth science
9. University of Kansas graduate student researcher takes aim at deadly brain tumors
10. Bioscience institutions come together to launch Microlife Discovery Center for area students
11. Biomedical engineering student recognized as IEEEs New Face of Engineering
Post Your Comments:
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
(Date:10/29/2015)... , Oct. 29, 2015  The J. Craig ... report titled, "DNA Synthesis and Biosecurity: Lessons Learned and ... Department of Health and Human Services guidance for synthetic ... 2010. --> --> ... also has the potential to pose unique biosecurity threats. ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... ... November 25, 2015 , ... ... Organization of Black Aerospace Professionals (OPBAP) has been formalized with the signing of ... team leaders met with OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn ...
(Date:11/24/2015)... Malaysia , Nov. 24, 2015  Asia-Pacific ... contract research organisation (CRO) market. The trend of ... in lower margins but higher volume share for ... capacity and scale, however, margins in the CRO ... Organisation (CRO) Market ( ), finds ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... Inc., a worldwide provider of clinical research services headquartered in ... has set a new quarterly earnings record in Q3 of 2015.  ... Q3 of 2014 to Q3 of 2015.   ... the establishment of an Asia-Pacific office to ... and Mexico , with the establishment ...
Breaking Biology Technology: